Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Randomized Controlled Trial of Non-inferiority of Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

NCT02130323 is registered in ClinicalTrials.gov with United States Naval Medical Center, San Diego as lead sponsor.

NCT NCT02130323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02130323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Randomized Controlled Trial of Non-inferiority of Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix
Lead sponsor
United States Naval Medical Center, San Diego
Phase
Phase 2/3
Overall status
Completed
Start date
February 28, 2015
Completion date
May 9, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia